Comment on “Fecal occult blood versus DNA testing: indirect comparison in a colorectal cancer screening population”

Comment on “Fecal occult blood versus DNA testing: indirect comparison in a colorectal cancer screening population”

David A Ahlquist Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USAChallenges to medical innovation are welcome and essential elements in the dialectic toward practice optimization but must be based on scientifically sound criticism. A multi-target stool DNA test (MT-sDNA)...

Full description

Bibliographic Details
Main Author:	Ahlquist DA
Format:	Article
Language:	English
Published:	Dove Medical Press 2017-08-01
Series:	Clinical Epidemiology
Subjects:	Colorectal cancer screening stool DNA fecal blood testing
Online Access:	https://www.dovepress.com/letter-fecal-occult-blood-versus-dna-testing-indirect-comparison--peer-reviewed-article-CLEP

Similar Items

Fecal occult blood versus DNA testing: indirect comparison in a colorectal cancer screening population
by: Brenner H, et al.
Published: (2017-07-01)

Effects of Fecal Occult Blood Immunoassay Screening for Colorectal Cancer—Experience from a Hospital in Central Taiwan
by: Pei-Yu Yang, et al.
Published: (2023-03-01)

Feasibility of quantification based on novel evaluation with stool DNA and fecal immunochemical test for colorectal cancer detection
by: Hongli Xu, et al.
Published: (2022-08-01)

Cause of Death, Mortality and Occult Blood in Colorectal Cancer Screening
by: Lasse Kaalby, et al.
Published: (2022-01-01)

Collection of non-meconium stool on fecal occult blood cards is an effective method for fecal microbiota studies in infants
by: Wendy S.W. Wong, et al.
Published: (2017-09-01)

Role of Immunological Method of Fecal Occult Blood Test for Screening Colorectal Diseases
by: Farida Yeasmin, et al.
Published: (2011-09-01)

Quantitative study of vimentin gene methylation in stool samples for colorectal cancer screening
by: Behfar Pakbaz, et al.
Published: (2019-01-01)

The Effects of Different Invitation Schemes on the Use of Fecal Occult Blood Tests for Colorectal Cancer Screening: Systematic Review of Randomized Controlled Trials
by: Laura F. Gruner, et al.
Published: (2021-03-01)

Effectiveness of Screening Using Fecal Occult Blood Testing and Colonoscopy on the Risk of Colorectal Cancer: The Japan Public Health Center-based Prospective Study
by: Kenta Tanaka, et al.
Published: (2023-02-01)

Colorectal Cancer Screening: Have We Addressed Concerns and Needs of the Target Population?
by: Thuy Ngan Tran, et al.
Published: (2021-10-01)

Stool Banking for Fecal Microbiota Transplantation: Methods and Operations at a Large Stool Bank
by: Justin Chen, et al.
Published: (2021-04-01)

Real‐world application of a fast stool DNA test for colorectal cancer screening in primary screening positive population
by: Yunfeng Zhu, et al.
Published: (2023-04-01)

Quantile-based fecal hemoglobin concentration for assessing colorectal neoplasms with 1,263,717 Taiwanese screenees
by: Szu-Min Peng, et al.
Published: (2019-05-01)

Use and abuse of fecal occult blood tests: a community hospital experience
by: Sarthak Soin, et al.
Published: (2019-09-01)

The Addition of Other Fecal Biomarkers Does Not Improve the Diagnostic Accuracy of Immunochemical Fecal Occult Blood Test Alone in a Colorrectal Cancer Screening Cohort
by: Gonzalo Hijos-Mallada, et al.
Published: (2021-06-01)

The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design
by: P. H. A. Wisse, et al.
Published: (2022-12-01)

Profiling small RNAs in fecal immunochemical tests: is it possible?
by: Einar Birkeland, et al.
Published: (2023-10-01)

The Non-Invasive Prediction of Colorectal Neoplasia (NIPCON) Study 1995–2022: A Comparison of Guaiac-Based Fecal Occult Blood Test (FOBT) and an Anti-Adenoma Antibody, Adnab-9
by: Martin Tobi, et al.
Published: (2023-12-01)

How Effective is a Fecal Occult Blood Test to Detect Malignancy?
by: Tarık Ahmet ŞAHİN, et al.
Published: (2022-03-01)

Factors influencing colorectal cancer screening decision-making among average-risk US adults
by: Xuan Zhu, et al.
Published: (2022-12-01)

Fecal microRNAs, Fecal microRNA Panels, or Combinations of Fecal microRNAs with Fecal Hemoglobin for Early Detection of Colorectal Cancer and Its Precursors: A Systematic Review
by: Zitong Zhao, et al.
Published: (2021-12-01)

Fecal microbiota transplantation and its potential therapeutic uses in gastrointestinal disorders
by: Ryan D. Heath, et al.
Published: (2018-02-01)

Usefullness of routine use of fecal occult blood test in a hospital setting
by: Simona Ravnik, et al.
Published: (2006-12-01)

Cost-effectiveness analysis of colonoscopy and fecal immunochemical testing for colorectal cancer screening in China
by: Yinan Ren, et al.
Published: (2022-08-01)

Fecal Immunochemical Tests for Colorectal Cancer Screening: Is Fecal Sampling from Multiple Sites Necessary?
by: Efrat L. Amitay, et al.
Published: (2019-03-01)

Potential of Fecal Carcinoembryonic Antigen for Noninvasive Detection of Colorectal Cancer: A Systematic Review
by: Xianzhe Li, et al.
Published: (2023-11-01)

From Donor to Patient: Collection, Preparation and Cryopreservation of Fecal Samples for Fecal Microbiota Transplantation
by: Carole Nicco, et al.
Published: (2020-04-01)

Evaluation of Blood Stool Test Utilization for Colorectal Cancer Screening in Georgia, USA
by: Benjamin E. Ansa, et al.
Published: (2021-05-01)

Self-perceived Mental Health Status and Uptake of Fecal Occult Blood Test for Colorectal Cancer Screening in Canada: A Cross-Sectional Study
by: Celestin Hategekimana, et al.
Published: (2016-06-01)

A fecal-based test for the detection of advanced adenoma and colorectal cancer: a case-control and screening cohort study
by: Lian-Jing Cao, et al.
Published: (2021-10-01)

Patterns of participation over four rounds of annual fecal immunochemical test-based screening for colorectal cancer: what predicts rescreening?
by: Joanne M. Osborne, et al.
Published: (2017-08-01)

Moderators of the effectiveness of an intervention to increase colorectal cancer screening through mailed fecal immunochemical test kits: results from a pragmatic randomized trial
by: Elizabeth A. O’Connor, et al.
Published: (2020-01-01)

Patterns of colorectal cancer screening and adherence rates among an average-risk population enrolled in a national health insurance provider during 2009–2018 in the United States
by: Henrik Kowalkowski, et al.
Published: (2023-12-01)

Pre- and post-sequencing recommendations for functional annotation of human fecal metagenomes
by: Michelle L. Treiber, et al.
Published: (2020-02-01)

The association between fecal enterotoxigenic B. fragilis with colorectal cancer
by: Fakhri Haghi, et al.
Published: (2019-09-01)

Patients without colonoscopic follow-up after abnormal fecal immunochemical tests are often unaware of the abnormal result and report several barriers to colonoscopy
by: Vivy T. Cusumano, et al.
Published: (2020-04-01)

Quality Improvement of Sample Collection Increases the Diagnostic Accuracy of Quantitative Fecal Immunochemical Test in Colorectal Cancer Screening: A Pilot Study
by: Ru-chen Zhou, et al.
Published: (2021-10-01)

Improvement of Asia-Pacific colorectal screening score and evaluation of its use combined with fecal immunochemical test
by: Xu-xia He, et al.
Published: (2019-12-01)

Diagnostic Performance of a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program According to Ambient Temperature and Humidity
by: Gemma Ibáñez-Sanz, et al.
Published: (2022-02-01)

A Comparison of Single and Combined Schemes of Asia-Pacific Colorectal Screening, Faecal Immunochemical and Stool Deoxyribonucleic Acid Testing for Community Colorectal Cancer Screening
by: Ze Y, et al.
Published: (2023-03-01)